426 related articles for article (PubMed ID: 8341998)
21. A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up.
Punnotok J; Pumprueg U; Chakorn T
J Med Assoc Thai; 1995 Jun; 78(6):298-304. PubMed ID: 7561554
[TBL] [Abstract][Full Text] [Related]
22. [A controlled survey comparing 2 short-term therapeutic regimes in lymph node tuberculosis].
Amrane R; Mazouni L; Boulahbal F; Abtroun N; Zidane C
Rev Mal Respir; 1989; 6(1):53-7. PubMed ID: 2648510
[TBL] [Abstract][Full Text] [Related]
23. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
24. Isoniazid induced gynaecomastia: a case report.
Garg R; Vaibhav ; Mehra S; Prasad R
Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
[TBL] [Abstract][Full Text] [Related]
25. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
[TBL] [Abstract][Full Text] [Related]
26. [Profile of the patients lost to treatment in the National Anti-Tuberculosis Program in Madagascar].
Rakotomanana F; Rabarijaona LP; Ratsitorahina M; Cauchoix B; Razafinimanana J; Ratsirahonana A; Boisier P; Aurégan G
Sante; 1999; 9(4):225-9. PubMed ID: 10623869
[TBL] [Abstract][Full Text] [Related]
27. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
Balasubramanian R; Nagarajan M; Balambal R; Tripathy SP; Sundararaman R; Venkatesan P; Paramasivam CN; Rajasambandam P; Rangabashyam N; Prabhakar R
Int J Tuberc Lung Dis; 1997 Feb; 1(1):44-51. PubMed ID: 9441058
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
Bellabas M; Khaled S; Khaled NA; Boulahbal F; Chaulet P
Rev Mal Respir; 1989; 6(1):59-64. PubMed ID: 2648511
[TBL] [Abstract][Full Text] [Related]
29. [Randomized control study on domestic fixed-dose combinations in the initial treatment of smears positive tuberculosis].
Xu WG; Lu W; He HJ; Gu XR
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):690-3. PubMed ID: 16201049
[TBL] [Abstract][Full Text] [Related]
30. [A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment].
Agounitestane D; Chiheb M; Khaled S; Ait Khaled N; Boulahbal F; Chaulet P
Rev Mal Respir; 1990; 7(3):209-13. PubMed ID: 2114029
[TBL] [Abstract][Full Text] [Related]
31. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
Eule H; Beck H; Evers H; Fischer P; Kwiatkowski H; Merkel S; Reech R; Sieler R; Thomas E; Weinecke W
Z Erkr Atmungsorgane; 1986; 167(1-2):29-41. PubMed ID: 3532585
[TBL] [Abstract][Full Text] [Related]
32. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
33. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
34. Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
Lincoln T; Brannan GL; Lynch V; Conklin TJ; Clancey T; Rose DN; Tuthill RJ
Int J Tuberc Lung Dis; 2004 Mar; 8(3):306-11. PubMed ID: 15139468
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
36. [Short term treatment of infantile pulmonary tuberculosis].
Garciá López JR; Vidal López ML; Castán Vidal ML; Borque Andrés C; de José Gómez MI; García Hortelano J
An Esp Pediatr; 1989 Aug; 31(2):110-3. PubMed ID: 2696390
[TBL] [Abstract][Full Text] [Related]
37. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
38. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
[TBL] [Abstract][Full Text] [Related]
39. Short-course drug therapy for tuberculosis.
Stratton MA; Reed MT
Clin Pharm; 1986 Dec; 5(12):977-87. PubMed ID: 3542345
[TBL] [Abstract][Full Text] [Related]
40. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
